![]() ![]() Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive Nigerian patients. Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon.Įxtraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients. High failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity HIV-1 genetic diversity and transmitted drug resistance mutations among patients from the North, Central and South regions of Angola.Įvaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries. Predominance of a rare type of HIV-1 in Estonia. ![]() ![]() Variability in HIV-1 Integrase Gene and 3'-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy. Near-Full-Length Genetic Characterization of a Novel HIV-1 Unique Recombinant with Similarities to A1, CRF01_AE, and CRFO2_AG Viruses in Yaoundé, Cameroon. Pre-existing HIV-1 integrase polymorphisms do not impact treatment response to elvitegravir-containing fixed-dose combination regimens in treatment-naive patients.ĭevelopment, validation and clinical evaluation of a low cost in-house HIV-1 drug resistance genotyping assay for Indian patients. Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness. Human immunodeficiency virus type 1 (HIV-1) subtypes in the northwest region, Cameroon. Molecular epidemiological analysis of paired pol/env sequences from Portuguese HIV type 1 patients. Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form. HIV-1 genetic diversity and drug resistance mutations among treatment-naive adult patients in Suriname.Įffectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Predominance of CRF06_cpx and Transmitted HIV Resistance in Algeria: Update 2013-2014.ĭrug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |